e-drug
[Top] [All Lists]

[e-drug] WHO Good Governance for Medicines Model Framework 2012 available for public comment

E-DRUG: WHO Good Governance for Medicines Model Framework 2012 available for 
public comment
------------------------------------------------------------------------------------

The World Health Report 2010 identifies 10 leading causes of health system 
inefficiency, 4 of which are related to medicines: prices, quality, use and 
waste. 

Pharmaceutical public system inefficiencies, unethical practices and corruption 
contribute to unnecessary expenditure on medicines and expose populations to 
substandard or counterfeit medicines.  In most countries, expenditure on 
pharmaceuticals comprises a large proportion of total health expenditure. 
Effective management and good governance in the pharmaceutical sector is 
therefore an essential element to improve efficiency and make a sustainable 
contribution to health systems strengthening and universal health coverage. 
Growing numbers of public health officials in Ministries of Health, National 
Medicines Regulatory Authorities and National Procurement Departments/Centers 
recognize the need for their institutions and personnel to work in more 
transparent and accountable environments an in accordance with ethical 
professional practices.

36 countries have participated in the Good Governance for Medicines Programme 
(GGM) applying the GGM principles of understanding the strengths and weaknesses 
of the country's pharmaceutical system and developing and applying appropriate 
interventions. A recent evaluation of the programme
 available at: www.who.int/medicines/areas/governance/en
 confirmed the need for strong support to countries for strengthening 
governance in the pharmaceutical sector.

To further support country efforts to implement good governance in the 
pharmaceutical sector, WHO has published the Good Governance for Medicines 
Model Framework. The model framework is a guideline that can be adapted by 
countries according to their needs. It proposes a combination of 
discipline-based and values-based strategies to countries for effective, 
efficient, ethical, transparent and accountable management of pharmaceutical 
systems.  The first edition of the framework was published in 2008 and then 
revised by experts and country representatives building on the experiences of 
work in the Good Governance for Medicines Programme.  

The 2012 version is now available at 
www.who.int/medicines/areas/policy/goodgovernance/
 for public comment until 15 October 2013.

Deirdre Dimancesco
Technical Officer
Medicines Policy, Governance and Information
Department of Essential Medicines and Health Products
World Health Organization
20 Ave Appia, 1211 Geneva, Switzerland
+41 22 791 4560
www.who.int/medicines
"DIMANCESCO, Deirdre" <dimancescod@who.int>


<Prev in Thread] Current Thread [Next in Thread>
  • [e-drug] WHO Good Governance for Medicines Model Framework 2012 available for public comment, DIMANCESCO, Deirdre <=